Loading…
Lobbying Spend
—
Filings
100
Firms Hired
4
Active Period
2000–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Lower Costs, More Transparency Act
2024 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act Prescription drug access and affordability, pricing, transparency, biosimilars, 340B
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2024 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars, 340B
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2024 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2023 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5378
Transparent PRICE Act
2023 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3281 Transparent P.R.I.C.E Act H.R.5801 Help Ensure Lower Patient Copays Act S.1339 the Pharmacy Benefit Manager Reform Act IRA implementation, prescription drug access and affordability, pricing, transparency
Client expense: — · Firm income: $60,000
Matched citations: H.R.3281
Preventing Overdoses with Test Strips Act
2023 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3281 Transparent P.R.I.C.E Act H.R.5801 Help Ensure Lower Patient Copays Act S.1339 the Pharmacy Benefit Manager Reform Act IRA implementation, prescription drug access and affordability, pricing, transparency
Client expense: — · Firm income: $60,000
Matched citations: H.R.5801
Pharmacy Benefit Manager Reform Act
2023 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3281 Transparent P.R.I.C.E Act H.R.5801 Help Ensure Lower Patient Copays Act S.1339 the Pharmacy Benefit Manager Reform Act IRA implementation, prescription drug access and affordability, pricing, transparency
Client expense: — · Firm income: $60,000
Matched citations: S.1339
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.2617, Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7667
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: S. 4348
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.2617, Consolidated Appropriations Act, 2023
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7667
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: S. 4348
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6833
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7667
H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 prescription drug access and affordability, pricing, transparency, user fee reauthorization
Client expense: — · Firm income: $60,000
Matched citations: S. 4348
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: TIBER CREEK GROUP
Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing). H.R.5376 - Inflation Reduction Act of 2022 - Public Law No: 117-169.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5376, H.R.5376
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: TIBER CREEK GROUP
Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); H.R.5376 - Inflation Reduction Act of 2022 - Public Law No: 117-169; Issues related to Prescription Drug User Fee Reauthorization; H.R. 6833 Affordable Insulin Now Act (Continuing Resolution Shell); H.R. 7667 - Food and Drug Amendments of 2022; S. 4348 - FDA Safety and Landmark Advancements (FDASLA) Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5376, H.R.5376
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · third_quarter · Firm: TIBER CREEK GROUP
Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); H.R.5376 - Inflation Reduction Act of 2022 - Public Law No: 117-169; Issues related to Prescription Drug User Fee Reauthorization; H.R. 6833 Affordable Insulin Now Act (Continuing Resolution Shell); H.R. 7667 - Food and Drug Amendments of 2022; S. 4348 - FDA Safety and Landmark Advancements (FDASLA) Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6833
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: TIBER CREEK GROUP
Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); H.R.5376 - Inflation Reduction Act of 2022 - Public Law No: 117-169; Issues related to Prescription Drug User Fee Reauthorization; H.R. 6833 Affordable Insulin Now Act (Continuing Resolution Shell); H.R. 7667 - Food and Drug Amendments of 2022; S. 4348 - FDA Safety and Landmark Advancements (FDASLA) Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7667
Source: Senate LDA